National estimates of HIV-related symptom prevalence from the HIV Cost and Services Utilization Study

Clicks: 428
ID: 116343
2000
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Star

Ranked #3 of 17 articles by views in Medical care

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
The prevalence and bothersomeness of HIV-related symptoms are substantial and vary by setting of care and patient characteristics.
Reference Key
wc2000medicalnational Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Mathews WC;McCutchan JA;Asch S;Turner BJ;Gifford AL;Kuromiya K;Brown J;Shapiro MF;Bozzette SA;;
Journal Medical care
Year 2000
DOI
DOI not found
URL
http://www.ncbi.nlm.nih.gov/pubmed/10901358
Keywords
National Center for Biotechnology Information NCBI NLM MEDLINE humans pubmed abstract nih national institutes of health national library of medicine research support non-u.s. gov't u.s. gov't adult female male adolescent middle aged P.H.S. United States severity of illness index hiv infections / complications* hiv infections / epidemiology Socioeconomic Factors prevalence costs and cost analysis cd4 lymphocyte count hiv infections / diagnosis hiv infections / economics pmid:10901358 doi:10.1097/00005650-200007000-00007 w c mathews j a mccutchan s a bozzette delivery of health care / statistics & numerical data hiv infections / etiology

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.